HEDGE FUNDS SHOULD BE ABLE TO CHALLENGE PATENT VALIDITY USING INTER PARTES REVIEW DESPITE MIXED MOTIVES.
- Published in:
- Houston Law Review, 2017, v. 54, n. 5, p. 1315
- By:
- Publication type:
- Article
Works matching DE "COALITION for Affordable Drugs (Company)"
Results: 1
1